Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Anthony Stuart

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Annals of Surgical Oncology|May 8, 2003
Thermal enhancement of new chemotherapeutic agents at moderate hyperthermiaFaheez Mohamed, Pierre Marchettini, O Anthony Stuart, et al.
International Journal of Surgical Oncology|February 8, 2012
Pharmacokinetic study of perioperative intravenous IfosfamideKurt Van der Speeten, O Anthony Stuart, Haile Mahteme, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 31, 2011
Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosisP H Sugarbaker, K Van der Speeten, O Anthony Stuart, et al.
Cancer Chemotherapy and Pharmacology|July 11, 2002
Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat modelPierre Marchettini, O Anthony Stuart, Faheez Mohamed, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2003
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokineticsVinicius de Lima Vazquez, O Anthony Stuart, Faheez Mohamed, et al.
Journal of Surgical Oncology|September 24, 2004
Docetaxel and hyperthermia: factors that modify thermal enhancementFaheez Mohamed, O Anthony Stuart, Olivier Glehen, et al.
Journal of Surgical Oncology|November 25, 2010
Pharmacology of perioperative 5-fluorouracilKurt Van der Speeten, O Anthony Stuart, Haile Mahteme, et al.
Cancer Chemotherapy and Pharmacology|April 15, 2006
Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumorFaheez Mohamed, O Anthony Stuart, Olivier Glehen, et al.
The Oncologist|February 15, 2005
Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapyPaul H Sugarbaker, Jorge Torres Mora, Pablo Carmignani, et al.
International Surgery|October 31, 2002
Prevention of intraperitoneal adhesions by intraperitoneal lavage and intraperitoneal 5-fluorouracil: experimental studiesSophie R Pestieau, Pierre Marchettini, O Anthony Stuart, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Annals of Surgical Oncology|May 8, 2003
Thermal enhancement of new chemotherapeutic agents at moderate hyperthermiaFaheez Mohamed, Pierre Marchettini, O Anthony Stuart, et al.
International Journal of Surgical Oncology|February 8, 2012
Pharmacokinetic study of perioperative intravenous IfosfamideKurt Van der Speeten, O Anthony Stuart, Haile Mahteme, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 31, 2011
Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosisP H Sugarbaker, K Van der Speeten, O Anthony Stuart, et al.
Cancer Chemotherapy and Pharmacology|July 11, 2002
Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat modelPierre Marchettini, O Anthony Stuart, Faheez Mohamed, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2003
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokineticsVinicius de Lima Vazquez, O Anthony Stuart, Faheez Mohamed, et al.
Journal of Surgical Oncology|September 24, 2004
Docetaxel and hyperthermia: factors that modify thermal enhancementFaheez Mohamed, O Anthony Stuart, Olivier Glehen, et al.
Journal of Surgical Oncology|November 25, 2010
Pharmacology of perioperative 5-fluorouracilKurt Van der Speeten, O Anthony Stuart, Haile Mahteme, et al.
Cancer Chemotherapy and Pharmacology|April 15, 2006
Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumorFaheez Mohamed, O Anthony Stuart, Olivier Glehen, et al.
The Oncologist|February 15, 2005
Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapyPaul H Sugarbaker, Jorge Torres Mora, Pablo Carmignani, et al.
International Surgery|October 31, 2002
Prevention of intraperitoneal adhesions by intraperitoneal lavage and intraperitoneal 5-fluorouracil: experimental studiesSophie R Pestieau, Pierre Marchettini, O Anthony Stuart, et al.
Pageof 4